BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8932343)

  • 1. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
    van den Berg J; Johannsson O; Håkansson S; Olsson H; Borg A
    Br J Cancer; 1996 Nov; 74(10):1615-9. PubMed ID: 8932343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
    Eiriksdottir G; Johannesdottir G; Ingvarsson S; Björnsdottir IB; Jonasson JG; Agnarsson BA; Hallgrimsson J; Gudmundsson J; Egilsson V; Sigurdsson H; Barkardottir RB
    Eur J Cancer; 1998 Dec; 34(13):2076-81. PubMed ID: 10070314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
    Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR
    Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
    Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
    Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of BRCA2 gene in sporadic breast tumours.
    Bièche I; Noguès C; Lidereau R
    Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
    Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
    Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
    Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
    Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer.
    Prechtel D; Werenskiold AK; Prechtel K; Keller G; Höfler H
    Diagn Mol Pathol; 1998 Feb; 7(1):57-62. PubMed ID: 9646036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
    Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
    Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB
    Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.
    Kerangueven F; Allione F; Noguchi T; Adélaïde J; Sobol H; Jacquemier J; Birnbaum D
    Genes Chromosomes Cancer; 1995 Aug; 13(4):291-4. PubMed ID: 7547638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).
    Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY
    Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
    Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
    Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
    Rio PG; Pernin D; Bay JO; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon DJ; Bignon YJ
    Int J Oncol; 1998 Oct; 13(4):849-53. PubMed ID: 9735416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
    Collins N; McManus R; Wooster R; Mangion J; Seal S; Lakhani SR; Ormiston W; Daly PA; Ford D; Easton DF
    Oncogene; 1995 Apr; 10(8):1673-5. PubMed ID: 7731724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.
    Bièche I; Noguès C; Rivoilan S; Khodja A; Latil A; Lidereau R
    Br J Cancer; 1997; 76(11):1416-8. PubMed ID: 9400936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
    Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
    Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
    Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
    Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.